![Uwe Salzer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uwe Salzer
Directeur/Membre du Conseil chez Esteve Pharmaceuticals Ltd.
Profil
Uwe Salzer is currently a Director at Esteve Pharmaceuticals Ltd.
He was previously a Director at Abbey Pharma Ltd.
Postes actifs de Uwe Salzer
Sociétés | Poste | Début |
---|---|---|
Esteve Pharmaceuticals Ltd.
![]() Esteve Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Esteve Pharmaceuticals Ltd. manufactures pharmaceutical products. It specializes in lactulose sachets, terra cortril, carbocisteine sachets, triamcinolone hexacetonide, naltrexone implants and generics. The company was founded in June 27, 1997 and is headquartered in Maidenhead, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Uwe Salzer
Sociétés | Poste | Fin |
---|---|---|
Abbey Pharma Ltd.
![]() Abbey Pharma Ltd. Pharmaceuticals: MajorHealth Technology Abbey Pharma Ltd. manufactures and distributes pharmaceutical products. Its products address therapeutic areas covering ophthalmology, oncology, pain, gastrointestinal, and dermatology. The company was founded in 2009 and is headquartered in Maidenhead, the United Kingdom. | Directeur/Membre du Conseil | 31/08/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Abbey Pharma Ltd.
![]() Abbey Pharma Ltd. Pharmaceuticals: MajorHealth Technology Abbey Pharma Ltd. manufactures and distributes pharmaceutical products. Its products address therapeutic areas covering ophthalmology, oncology, pain, gastrointestinal, and dermatology. The company was founded in 2009 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Esteve Pharmaceuticals Ltd.
![]() Esteve Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Esteve Pharmaceuticals Ltd. manufactures pharmaceutical products. It specializes in lactulose sachets, terra cortril, carbocisteine sachets, triamcinolone hexacetonide, naltrexone implants and generics. The company was founded in June 27, 1997 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |